Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: 12400 High Bluff Drive
SAN DIEGO CA 92130
Tel: N/A
Website: https://www.tandemdiabetes.com
IR: See website
<
Key People
Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Elizabeth A. Gasser
Executive Vice President, Chief Strategy Officer
Brian B. Hansen
Chief Commercial Officer, Executive Vice President
James A. Leal
Senior Vice President - Operations
Rick Carpenter
Chief Technical Officer
Business Overview
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Financial Overview
For the fiscal year ended 31 December 2023, Tandem Diabetes Care Inc revenues decreased 7% to $747.7M. Net loss increased from $94.6M to $222.6M. Revenues reflect Pump segment decrease of 13% to $374.3M. Higher net loss reflects Acquired in-process research and develop increase from $31M to $78.8M (expense), Research and development - Balancing val increase of 21% to $144.1M (expense).
Employees: 2,400 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $1,847M as of Dec 31, 2023
Annual revenue (TTM): $747.72M as of Dec 31, 2023
EBITDA (TTM): -$206.29M as of Dec 31, 2023
Net annual income (TTM): -$222.61M as of Dec 31, 2023
Free cash flow (TTM): -$83.41M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 65,631,041 as of Feb 16, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.